Update: 09.09.2025
Last week: 35 week 2025 (25.08.2025 - 31.08.2025)
Last full month: August 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 696 | 1.8% | 14.3% | 0.2 | 20 236 344 | 2.2% | 10.8% | 0.2 | 0.4% |
| MoM | 36 668 | 3.5% | 14.1% | 0.1 | 84 968 932 | 3.2% | 10.6% | -0.1 | 2.8% |
| YTD | 309 908 | 20.7% | 13.2% | 1.5 | 692 310 924 | 27.3% | 9.9% | 0.4 | 7.1% |
| MAT | 474 673 | 22.9% | 13.3% | 2.3 | 987 612 088 | 22.1% | 9.6% | 0.6 | 1.4% |
| BRAINMAX | |||||||||
| WoW | 1 727 | -12.2% | 100.0% | 0 | 6 002 574 | -14.4% | 100.0% | 0 | -12.2% |
| MoM | 8 534 | 2.0% | 100.0% | 0 | 30 008 435 | 3.6% | 100.0% | 0 | 2.0% |
| YTD | 80 502 | 89.3% | 100.0% | 0 | 278 765 430 | 85.6% | 100.0% | 0 | 89.3% |
| MAT | 120 639 | 94.1% | 100.0% | 0 | 415 324 944 | 89.3% | 100.0% | 0 | 94.1% |
| GOLDLINE PLUS | |||||||||
| WoW | 12 343 | -2.3% | 46.3% | 0.3 | 41 847 515 | 0.5% | 38.1% | 0.3 | -2.8% |
| MoM | 56 909 | -3.8% | 45.9% | -0.9 | 188 693 462 | -2.8% | 37.6% | -0.8 | -2.0% |
| YTD | 541 009 | -7.5% | 45.8% | 0.8 | 1 752 083 089 | -4.8% | 37.5% | 0.7 | -9.2% |
| MAT | 785 090 | -6.4% | 46.0% | 0.7 | 2 513 717 942 | -5.1% | 37.6% | -0.1 | -7.7% |
| MIGRENIUM | |||||||||
| WoW | 8 105 | -1.4% | 0.3% | 0 | 2 870 578 | -1.9% | 0.5% | 0 | -1.2% |
| MoM | 35 983 | 7.1% | 0.3% | 0 | 12 764 211 | 6.9% | 0.5% | 0 | 4.2% |
| YTD | 283 365 | -31.1% | 0.3% | -0.2 | 99 836 895 | -22.1% | 0.5% | -0.2 | 5.0% |
| MAT | 439 873 | -26.9% | 0.4% | -0.1 | 153 348 371 | -9.1% | 0.5% | -0.1 | 2.5% |
| MODELAX-N | |||||||||
| WoW | 24 458 | -1.7% | 19.1% | 0.4 | 13 879 004 | -2.2% | 14.0% | 0.1 | -3.7% |
| MoM | 109 386 | -0.2% | 18.8% | -0.1 | 62 929 768 | 2.9% | 14.0% | 0.3 | 0.3% |
| YTD | 976 518 | -3.3% | 20.0% | -2.6 | 525 881 532 | 20.2% | 14.5% | -0.1 | 9.2% |
| MAT | 1 430 554 | 1.1% | 20.0% | -1.3 | 747 676 242 | 29.0% | 14.1% | 0.9 | 7.6% |
| REDUXIN | |||||||||
| WoW | 8 558 | -3.4% | 32.1% | -0.2 | 48 026 695 | -0.3% | 43.7% | 0 | -2.8% |
| MoM | 40 074 | 0.3% | 32.3% | 0.7 | 219 573 916 | 1.5% | 43.8% | 1 | -2.0% |
| YTD | 374 381 | -12.5% | 31.7% | -1.2 | 2 042 563 363 | -10.6% | 43.7% | -2 | -9.2% |
| MAT | 541 891 | -9.6% | 31.8% | -0.7 | 2 921 561 940 | -6.8% | 43.7% | -0.9 | -7.7% |
| REDUXIN FORTE | |||||||||
| WoW | 2 720 | -3.0% | 10.2% | 0 | 12 954 477 | -2.7% | 11.8% | -0.3 | -2.8% |
| MoM | 12 848 | -2.5% | 10.4% | -0.1 | 60 988 448 | -1.5% | 12.2% | -0.1 | -2.0% |
| YTD | 119 245 | 3.0% | 10.1% | 1.2 | 547 057 145 | 9.3% | 11.7% | 1.7 | -9.2% |
| MAT | 170 785 | 2.7% | 10.0% | 1 | 768 468 848 | 8.2% | 11.5% | 1.4 | -7.7% |
| SALVISAR | |||||||||
| WoW | 10 049 | -1.1% | 1.5% | 0 | 5 478 527 | -1.5% | 1.5% | 0 | -2.6% |
| MoM | 42 810 | 13.5% | 1.4% | 0.2 | 23 255 651 | 14.8% | 1.4% | 0.2 | 1.1% |
| YTD | 408 116 | 17.5% | 1.6% | 0.3 | 206 830 192 | 45.7% | 1.6% | 0.4 | -3.0% |
| MAT | 632 555 | 25.1% | 1.7% | 0.4 | 305 819 180 | 57.3% | 1.6% | 0.5 | -4.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 309 908 | 20.7% | 13.2% | 1.5 | 692 310 924 | 27.3% | 9.9% | 0.4 | 7.1% |
| BRAINMAX | 80 502 | 89.3% | 100.0% | 0 | 278 765 430 | 85.6% | 100.0% | 0 | 89.3% |
| GOLDLINE PLUS | 541 009 | -7.5% | 45.8% | 0.8 | 1 752 083 089 | -4.8% | 37.5% | 0.7 | -9.2% |
| MIGRENIUM | 283 365 | -31.1% | 0.3% | -0.2 | 99 836 895 | -22.1% | 0.5% | -0.2 | 5.0% |
| MODELAX-N | 976 518 | -3.3% | 20.0% | -2.6 | 525 881 532 | 20.2% | 14.5% | -0.1 | 9.2% |
| REDUXIN CAPS | 374 381 | -12.5% | 31.7% | -1.2 | 2 042 563 363 | -10.6% | 43.7% | -2 | -9.2% |
| REDUXIN FORTE | 119 245 | 3.0% | 10.1% | 1.2 | 547 057 145 | 9.3% | 11.7% | 1.7 | -9.2% |
| SALVISAR | 408 116 | 17.5% | 1.6% | 0.3 | 206 830 192 | 45.7% | 1.6% | 0.4 | -3.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 474 673 | 22.9% | 13.3% | 2.3 | 987 612 088 | 22.1% | 9.6% | 0.6 | 1.4% |
| BRAINMAX | 120 639 | 94.1% | 100.0% | 0 | 415 324 944 | 89.3% | 100.0% | 0 | 94.1% |
| GOLDLINE PLUS | 785 090 | -6.4% | 46.0% | 0.7 | 2 513 717 942 | -5.1% | 37.6% | -0.1 | -7.7% |
| MIGRENIUM | 439 873 | -26.9% | 0.4% | -0.1 | 153 348 371 | -9.1% | 0.5% | -0.1 | 2.5% |
| MODELAX-N | 1 430 554 | 1.1% | 20.0% | -1.3 | 747 676 242 | 29.0% | 14.1% | 0.9 | 7.6% |
| REDUXIN CAPS | 541 891 | -9.6% | 31.8% | -0.7 | 2 921 561 940 | -6.8% | 43.7% | -0.9 | -7.7% |
| REDUXIN FORTE | 170 785 | 2.7% | 10.0% | 1 | 768 468 848 | 8.2% | 11.5% | 1.4 | -7.7% |
| SALVISAR | 632 555 | 25.1% | 1.7% | 0.4 | 305 819 180 | 57.3% | 1.6% | 0.5 | -4.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 696 | 1.8% | 14.3% | 0.2 | 20 236 344 | 2.2% | 10.8% | 0.2 | 0.4% |
| BRAINMAX | 1 727 | -12.2% | 100.0% | 0 | 6 002 574 | -14.4% | 100.0% | 0 | -12.2% |
| GOLDLINE PLUS | 12 343 | -2.3% | 46.3% | 0.3 | 41 847 515 | 0.5% | 38.1% | 0.3 | -2.8% |
| MIGRENIUM | 8 105 | -1.4% | 0.3% | 0 | 2 870 578 | -1.9% | 0.5% | 0 | -1.2% |
| MODELAX-N | 24 458 | -1.7% | 19.1% | 0.4 | 13 879 004 | -2.2% | 14.0% | 0.1 | -3.7% |
| REDUXIN CAPS | 8 558 | -3.4% | 32.1% | -0.2 | 48 026 695 | -0.3% | 43.7% | 0 | -2.8% |
| REDUXIN FORTE | 2 720 | -3.0% | 10.2% | 0 | 12 954 477 | -2.7% | 11.8% | -0.3 | -2.8% |
| SALVISAR | 10 049 | -1.1% | 1.5% | 0 | 5 478 527 | -1.5% | 1.5% | 0 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 668 | 3.5% | 14.1% | 0.1 | 84 968 932 | 3.2% | 10.6% | -0.1 | 2.8% |
| BRAINMAX | 8 534 | 2.0% | 100.0% | 0 | 30 008 435 | 3.6% | 100.0% | 0 | 2.0% |
| GOLDLINE PLUS | 56 909 | -3.8% | 45.9% | -0.9 | 188 693 462 | -2.8% | 37.6% | -0.8 | -2.0% |
| MIGRENIUM | 35 983 | 7.1% | 0.3% | 0 | 12 764 211 | 6.9% | 0.5% | 0 | 4.2% |
| MODELAX-N | 109 386 | -0.2% | 18.8% | -0.1 | 62 929 768 | 2.9% | 14.0% | 0.3 | 0.3% |
| REDUXIN CAPS | 40 074 | 0.3% | 32.3% | 0.7 | 219 573 916 | 1.5% | 43.8% | 1 | -2.0% |
| REDUXIN FORTE | 12 848 | -2.5% | 10.4% | -0.1 | 60 988 448 | -1.5% | 12.2% | -0.1 | -2.0% |
| SALVISAR | 42 810 | 13.5% | 1.4% | 0.2 | 23 255 651 | 14.8% | 1.4% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs